Drug intelligence / Profile preview

Thespesia populnea extract

Development stage: Preclinical
Administration: Oral, Topical

Overview

Thespesia populnea extract is derived from the Thespesia populnea plant, which is valued for its diverse therapeutic properties. It exhibits anti-inflammatory, antimicrobial, antioxidant, antipsoriatic, antidiarrheal, anticancer, and potential anti-Alzheimer's effects. The extract is rich in bioactive compounds such as flavonoids, sesquiterpenoids, tannins, saponins, and essential oils. It is traditionally used in Ayurvedic medicine for various health conditions and shows potential in wound healing and managing skin diseases.

Other names: Thespesia populneaParas-pipalPortia treeIndian Tulip Tree

Targets

PRKCG (Protein kinase C gamma)MAPK3 (Mitogen-activated protein kinase 1)PRKCA (Protein kinase C alpha)

Beyond the preview

Go deeper on Thespesia populnea extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thespesia populnea extract.

Explore the full profile